209 related articles for article (PubMed ID: 27770210)
21. Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
Takayama K; Someya H; Yokoyama H; Kimura T; Takamura Y; Morioka M; Sameshima S; Ueda T; Ogata N; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Acta Ophthalmol; 2020 Jun; 98(4):e434-e439. PubMed ID: 31674137
[TBL] [Abstract][Full Text] [Related]
22. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH; Chen MS
Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
[TBL] [Abstract][Full Text] [Related]
23. Soloist performance of vitrectomy probe in proliferative diabetic retinopathy.
Elwan MM; Hagras SM; Kasem MA
Eur J Ophthalmol; 2019 Mar; 29(2):251-256. PubMed ID: 29972027
[TBL] [Abstract][Full Text] [Related]
24. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
Lee DY; Jeong HS; Sohn HJ; Nam DH
Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
[TBL] [Abstract][Full Text] [Related]
25. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
[TBL] [Abstract][Full Text] [Related]
26. Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy.
Nishi K; Nishitsuka K; Yamamoto T; Yamashita H
PLoS One; 2021; 16(1):e0244281. PubMed ID: 33444332
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Ferenchak K; Duval R; Cohen JA; MacCumber MW
Retina; 2014 Jun; 34(6):1177-81. PubMed ID: 24457977
[TBL] [Abstract][Full Text] [Related]
28. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
Bouchard O; Zech JC; Trepsat C
J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
[TBL] [Abstract][Full Text] [Related]
29. Late postoperative vitreous cavity hemorrhage after vitrectomy for proliferative diabetic retinopathy-observation versus intervention.
Brar AS; Behera UC; Karande S; Kanakagiri A; Sugumar S; Rani PK; Vignesh TP; Manayath G; Salian R; Giridhar A; Indurkhya S; Bhattacharjee H; Raman R; Sivaprasad S
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S22-S26. PubMed ID: 38131537
[TBL] [Abstract][Full Text] [Related]
30. Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy.
Naruse Z; Shimada H; Mori R
Int Ophthalmol; 2019 Sep; 39(9):1973-1980. PubMed ID: 30284092
[TBL] [Abstract][Full Text] [Related]
31. Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal detachment secondary to proliferative diabetic retinopathy.
Chen PL; Chen YT; Chen SN
PLoS One; 2021; 16(3):e0249139. PubMed ID: 33765074
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.
Jirawison C; Ittipunkul N
J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866
[TBL] [Abstract][Full Text] [Related]
33. Predictors of postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy.
Motoda S; Shiraki N; Ishihara T; Sakaguchi H; Kabata D; Takahara M; Kimura T; Kozawa J; Imagawa A; Nishida K; Shintani A; Iwahashi H; Shimomura I
J Diabetes Investig; 2018 Jul; 9(4):940-945. PubMed ID: 29265703
[TBL] [Abstract][Full Text] [Related]
34. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
35. Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography.
Steel DH; Habib MS; Park S; Hildreth AJ; Owen RI
Ophthalmology; 2008 Mar; 115(3):525-32. PubMed ID: 17976729
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of higher cutting rates during microincision vitrectomy for proliferative diabetic retinopathy.
Sano M; Inoue M; Itoh Y; Hirota K; Koto T; Hirakata A
Eur J Ophthalmol; 2016 Jun; 26(4):364-8. PubMed ID: 26692058
[TBL] [Abstract][Full Text] [Related]
37. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
[TBL] [Abstract][Full Text] [Related]
38. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
Li X; Jiang Y; Ye C; Li C
Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
Yeh PT; Yang CH; Yang CM
Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
[TBL] [Abstract][Full Text] [Related]
40. Early postoperative intraocular pressure stability after combined 23-gauge sutureless vitrectomy and cataract surgery in patients with proliferative diabetic retinopathy.
Lee JY; Jeong HS; Lee DY; Sohn HJ; Nam DH
Retina; 2012 Oct; 32(9):1767-74. PubMed ID: 22481480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
